News

Healthcare

​EyeGate's Potential is in Making a Trusted Substance Even Better

​EyeGate's Potential is in Making a Trusted Substance Even Better

Stephen L Kanaval | Equities.com |

Eyegate's OBG solution has a chance for commercialization in 2019


How Artificial Intelligence is Transforming Clinical Trial Recruitment

Visual Capitalist | Equities.com |

Poor clinical trial recruitment can cause losses up to $8 million each day. How can health and pharma companies get better at finding the right patients?


Stable Premiums, More Options as Health Law Sign-Ups Begin

Associated Press | Equities.com |

The Affordable Care Act's sixth sign-up season opens Thursday amid stabilizing premiums and more choice for consumers.


US Approves First New Type of Flu Drug in 2 Decades

Associated Press | Equities.com |

Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season.


Cancer Research Highlights: Week of October 15

Zachary Hartman | Equities.com |

Highlights for the week that ESMO 2018 began. Oncology news had important implications for investors across the space


Drugmakers to Disclose Prices for Medicines Advertised on TV

Associated Press | Equities.com |

The prices won't actually be shown in the TV commercials but the advertisement will include a website where the list price will be posted.


Biotech's Cancer Investing Highlights: October 1-5

Zachary Hartman | Equities.com |

Highlights from the week in cancer research that may be important for investors in the biotech space


Osmotica Pharmaceuticals' $125 Million IPO Expected Next Week

Equities Research | Equities.com |

$246 million in revenue in 2017 from specialty neurology, women's health and generics. Phase 3 in MS and droopy eyelid (Image: Osmotica Pharmaceuticals).


Is DaVita Inc. (DVA) a Good Buy for Value Investors?

Jacob Maslow | Equities.com |

Davita is a good stock to keep an eye on.


The Amazonification of Healthcare

Visual Capitalist | Equities.com |

The healthcare industry is being transformed, unlocking a completely new patient experience that some are calling the ‘Amazonification’ of healthcare.


Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Events

The MoneyShow Orlando

Attend the largest gathering of Wall Street's most experienced and insightful experts in Orlando this winter and get the best investing and trading education money can buy—for FREE!

Learn more